Ecosystem Intelligence PlatformEcosystem Intelligence PlatformPowered by Novaria.ai
Back to directory
U

Ultromics.com

FDA-cleared AI platform that automatically detects heart failure and cardiac amyloidosis from echocardiogram scans.

About

Ultromics provides clinically validated, AI-powered medical devices that analyse routine echocardiograms to diagnose complex cardiac diseases, including HFpEF and cardiac amyloidosis. The EchoGo® platform integrates seamlessly into hospital and clinic workflows, delivering automated diagnostic reports in under 20 minutes with 90% sensitivity for HFpEF detection. Founded at the University of Oxford and backed by government and leading VCs, Ultromics has expanded to 50+ global sites and is reimbursable under Medicare.

Core use cases

  • HFpEF detection from echocardiograms
  • Cardiac amyloidosis detection
  • Automated diagnostic reporting for cardiology
AI type
AI-native
Primary product type
Scoring & Classification Engine
Secondary product type
AI Governance Tool

Product

Sign up free to see product details, features and pricing.

Create free account

Commercial

Sign up free to see pricing model, tiers and contract terms.

Create free account

Market

Upgrade to Intelligence to see market positioning, target buyers and geographic focus.

Upgrade to Intelligence

Traction

Upgrade to Intelligence to see awards, analyst coverage and ratings.

Upgrade to Intelligence

Funding & Team

Upgrade to Intelligence to see funding history, team size and key executives.

Upgrade to Intelligence

Trust & Compliance

Upgrade to Intelligence to see security certifications, compliance and SLA details.

Upgrade to Intelligence

Market Context

Upgrade to Intelligence to see competitors, market maturity and press coverage.

Upgrade to Intelligence

Similar companies